---
title: "Bio-Techne 下一季度財報的預期"
description: "Bio-Techne 下一個季度財報可以期待什麼？"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/209613450.md"
published_at: "2024-07-23T14:27:35.000Z"
---

# Bio-Techne 下一季度財報的預期

> Bio-Techne 下一個季度財報可以期待什麼？

Bio-Techne 下一個季度財報可以期待什麼？

### Related Stocks

- [TECH.US - Bio-Techne](https://longbridge.com/zh-HK/quote/TECH.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Bio-Techne Names Steve Crouse President of Diagnostics and Spatial Biology Segment | Bio-Techne Corporation announced that Dr. Matt McManus will step down as President of the Diagnostics and Spatial Biolog | [Link](https://longbridge.com/zh-HK/news/275618046.md) |
| Bio-Techne Q2 Earnings Report: What Investors Need to Know | Bio-Techne (NASDAQ:TECH) reported its Q2 earnings on February 4, 2026, beating estimated earnings by 15% with an EPS of  | [Link](https://longbridge.com/zh-HK/news/274804035.md) |
| Biotech firm Bio-Techne beats quarterly estimates on strength in key unit | Biotech firm Bio-Techneexceeded analysts' expectations for Q2 revenue and profit, driven by strong demand for its drug d | [Link](https://longbridge.com/zh-HK/news/274818514.md) |
| Bio-Techne Corporation kündigt Quartalsdividende von 0,08 US-Dollar je Aktie an | Bio-Techne Corporation has announced a quarterly dividend of $0.08 per share for the quarter ending December 31, 2025. T | [Link](https://longbridge.com/zh-HK/news/274802498.md) |
| Bio-Techne: Near-Term Resilience and Margin Expansion Support Accelerating Growth and Buy Rating Into 2027 | Citi analyst Patrick B Donnelly has maintained a Buy rating on Bio-Techne with a price target of $80.00. He cites near-t | [Link](https://longbridge.com/zh-HK/news/274873127.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。
